Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Schulman Marcus, Joshua ^a   Prabhakaran, Dorairaj ^b   Gaziano, Thomas A ^c,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

ACCURACY; ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEVELOPED COUNTRY; DRUG COST; ELECTROCARDIOGRAM; EMERGENCY CARE; GENERAL PRACTITIONER; HUMAN; INDIA; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; THORAX PAIN; URBAN AREA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; GENERAL PRACTICE; METHODOLOGY; URBAN POPULATION;

ACUTE CORONARY SYNDROME; COST-BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FAMILY PRACTICE; HUMANS; INDIA; URBAN POPULATION;

EID: 77951182711     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-13     Document Type: Article

References (50)

1. Karthikeyan G, Xavier D, Prabhakaran D, Pais P. Perspectives on the management of coronary artery disease in India. Heart 2007, 93(11):1334-1338. 10.1136/hrt.2007.131193, 17933988.
2. Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol 2007, 50(14):1370-1372. 10.1016/j.jacc.2007.04.097, 17903637.
3. Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks. Global and regional burden of disease attributable to major risk factors. 2004, Geneva: World Health Organization.
4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110(9):e82-292.
5. API expert consensus document on management of ischemic heart disease. J Assoc Physicians India 2006, 54:469-480.
6. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008, 371(9622):1435-1442. 10.1016/S0140-6736(08)60623-6, 18440425.
7. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006, 27(19):2285-2293. 10.1093/eurheartj/ehl196, 16908490.
8. Rajagopalan RE, Chandrasekaran S, Pai M, Rajaram R, Mahendran S. Pre-hospital delay in acute myocardial infarction in an urban Indian hospital: a prospective study. Natl Med J India 2001, 14(1):8-12.
9. Malhotra S, Gupta M, Chandra KK, Grover A, Pandhi P. Prehospital delay in patients hospitalized with acute myocardial infarction in the emergency unit of a North Indian tertiary care hospital. Indian Heart J 2003, 55(4):349-353.
10. Diercks DB, Kontos MC, Chen AY, Pollack CV, Wiviott SD, Rumsfeld JS, Magid DJ, Gibler WB, Cannon CP, Peterson ED, et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J Am Coll Cardiol 2009, 53(2):161-166. 10.1016/j.jacc.2008.09.030, 19130984.
11. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, Walshon J, Terranova G, Gottlieb L, Goldstein-Wayne B, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987, 60(4):219-224. 10.1016/0002-9149(87)90217-7, 3618483.
12. Pozen MW, D'Agostino RB, Selker HP, Sytkowski PA, Hood WB. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med 1984, 310(20):1273-1278.
13. Karlson BW, Herlitz J, Wiklund O, Richter A, Hjalmarson A. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol 1991, 68(2):171-175. 10.1016/0002-9149(91)90739-8, 2063777.
14. Ting HH, Lee TH, Soukup JR, Cook EF, Tosteson AN, Brand DA, Rouan GW, Goldman L. Impact of physician experience on triage of emergency room patients with acute chest pain at three teaching hospitals. Am J Med 1991, 91(4):401-408. 10.1016/0002-9343(91)90158-T, 1951384.
15. Selker HP, Beshansky JR, Griffith JL, Aufderheide TP, Ballin DS, Bernard SA, Crespo SG, Feldman JA, Fish SS, Gibler WB, et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann Intern Med 1998, 129(11):845-855.
16. Mant J, McManus RJ, Oakes RA, Delaney BC, Barton PM, Deeks JJ, Hammersley L, Davies RC, Davies MK, Hobbs FD. Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. Health Technol Assess 2004, 8(2):iii. 1-158.
17. Herlitz J, Karlson BW, Karlsson T, Dellborg M, Hartford M, Luepker R. Diagnostic accuracy of physicians for identifying patients with acute myocardial infarction without an electrocardiogram. Experiences from the TEAHAT Trial. Cardiology 1995, 86(1):25-27. 10.1159/000176831, 7728784.
18. Gold M, Siegel J, Russell L, M W, . eds Cost-effectiveness in health and medicine. 1996, New York: Oxford University Press, eds.
19. Davie AP, Caesar D, Caruana L, Clegg G, Spiller J, Capewell S, Starkey IR, Shaw TR, McMurray JJ. Outcome from a rapid-assessment chest pain clinic. QJM 1998, 91(5):339-343. 10.1093/qjmed/91.5.339, 9709467.
20. Burt CW. Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996. Am J Emerg Med 1999, 17(6):552-559. 10.1016/S0735-6757(99)90195-X, 10530533.
21. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, Griffith JL, Selker HP. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000, 342(16):1163-1170. 10.1056/NEJM200004203421603, 10770981.
22. Herlitz J, Karlson BW, Karlsson T, Stensdotter L, Sjolin M. Rate of admission and long-term prognosis among patients with acute chest pain in the 1990s compared with the 1980s. Cardiology 2005, 104(1):51-56. 10.1159/000086525, 15983436.
23. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988, 2(8607):349-360. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
24. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 1998, 316(7141):1337-1343. 28530, 9563981.
25. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343(8893):311-322. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
26. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005, 366(9497):1622-1632. 10.1016/S0140-6736(05)67661-1, 16271643.
27. Rodriguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, La Vecchia C. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006, 92(4):453-460. 10.1136/hrt.2004.059295, 1860892, 16537758.
28. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 2002, 162(21):2405-2410. 10.1001/archinte.162.21.2405, 12437397.
29. Mendis S, Abegunde D, Yusuf S, Ebrahim S, Shaper G, Ghannem H, Shengelia B. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ 2005, 83(11):820-829. 2626468, 16302038.
30. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324(7329):71-86. 10.1136/bmj.324.7329.71, 64503, 11786451, Antithrombotic Trialists' Collaboration.
31. Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 2006, 368(9535):581-588. 10.1016/S0140-6736(06)69201-5, 16905022.
32. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999, 318(7200):1730-1737. 31101, 10381708.
33. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339(19):1349-1357. 10.1056/NEJM199811053391902, 9841303, The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
34. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27(5):335-371. 10.1016/S0033-0620(85)80003-7, 2858114.
35. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans DB, et al. Disease control priorities in developing countries. 2006, New York: Oxford University Press and the World Bank, 2.
36. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. Global Burden of Disease and Risk Factors 2006, 45-93. New York: Oxford University Press.
37. Mulligan J, Fox-Rushby J, Taghreed A. Unit costs of health care inputs in low and middle income regions. Disease Control Priorities Project Working Paper 9, Bethesda (MD) 2004,
38. Fyre J, . ed International drug price indicator guide. 2008, Cambridge (MA): Management Sciences for Health, ed.
39. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004, 328(7443):807-810. 10.1136/bmj.328.7443.807, 383378, 15070638.
40. Shafey O, Eriksen M, Ross H, Mackay J. The Tobacco Atlas, Third Edition. 2009, Atlanta: American Cancer Society.
41. Ahmad N, Bhopal R. Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease. Heart 2005, 91(6):719-725. 10.1136/hrt.2003.031047, 1768945, 15894760.
42. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006, 124(3):235-244.
43. Jafar TH, Qadri Z, Chaturvedi N. Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. Heart 2008, 94(4):408-413. 10.1136/hrt.2007.120774, 2565583, 17646192.
44. Joshi R, Chow CK, Raju PK, Raju R, Reddy KS, MacMahon S, Lopez AD, Neal B. Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India. Circulation 2009, 119(14):1950-1955. 10.1161/CIRCULATIONAHA.108.819201, 19332466.
45. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952. 10.1016/S0140-6736(04)17018-9, 15364185.
46. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985, 5(2):157-177. 10.1177/0272989X8500500205, 3831638.
47. Macroeconomics and health: investing in health for economic development. 2001, Geneva: World Health Organization.
48. S Mauss FB, Schmutz G, Henke J, Richter WO. Lipoprotein(a) in patients initiating antiretroviral therapy. HIV Medicine 2008, 9(6):415-420. 10.1111/j.1468-1293.2008.00574.x, 18459949.
49. Roger VL, Killian JM, Weston SA, Jaffe AS, Kors J, Santrach PJ, Tunstall-Pedoe H, Jacobsen SJ. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 2006, 114(8):790-797. 10.1161/CIRCULATIONAHA.106.627505, 16908764.
50. Gaziano TA. Cardiovascular Disease in the Developing World and Its Cost-Effective Management. Circulation 2005, 112(23):3547-3553. 10.1161/CIRCULATIONAHA.105.591792, 16330695.